The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53
Related Experiment Video
Updated: Jul 29, 2026

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
N D Lakin1, B C Hann, S P Jackson
1Wellcome Trust/Cancer Research Campaign Institute of Cancer and Developmental Biology, Department of Zoology, Cambridge University, UK.
Abstract:
Levels of the tumour suppressor protein p53 are increased in response to a variety of DNA damaging agents. DNA damage-induced phosphorylation of p53 occurs at serine-15 in vivo. Phosphorylation of p53 at serine-15 leads to a stabilization of the polypeptide by inhibiting its interaction with Mdm2, a protein that targets p53 for ubiquitin-dependent degradation. However, the mechanisms by which DNA damage is signalled to p53 remain unclear. Here, we report the identification of a novel DNA-activated protein kinase that phosphorylates p53 on serine-15. Fractionation of HeLa nuclear extracts and biochemical analyses indicate that this kinase is distinct from the DNA-dependent protein kinase (DNA-PK) and corresponds to the human cell cycle checkpoint protein ATR. Immunoprecipitation studies of recombinant ATR reveal that catalytic activity of this polypeptide is required for DNA-stimulated phosphorylation of p53 on serine-15. These data suggest that ATR may function upstream of p53 in a signal transduction cascade initiated upon DNA damage and provide a biochemical assay system for ATR activity.
Insights
Researchers identified a novel DNA-activated protein kinase, ATR, that phosphorylates tumor suppressor p53 at serine-15. This discovery clarifies a key step in DNA damage signaling to p53.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Cancer Research
Background:
- The tumor suppressor protein p53 is stabilized upon DNA damage through phosphorylation at serine-15.
- This phosphorylation event inhibits p53's interaction with Mdm2, preventing its degradation.
- The precise signaling pathway linking DNA damage to p53 phosphorylation remains incompletely understood.
Purpose of the Study:
- To identify the novel DNA-activated protein kinase responsible for phosphorylating p53 at serine-15.
- To elucidate the role of this kinase in the DNA damage response pathway.
- To establish a biochemical assay for studying this kinase's activity.
Main Methods:
- Fractionation of HeLa nuclear extracts.
- Biochemical analyses to characterize kinase activity.
- Immunoprecipitation studies using recombinant ATR.
Main Results:
- A novel DNA-activated protein kinase was identified that phosphorylates p53 on serine-15.
- This kinase was found to be distinct from DNA-dependent protein kinase (DNA-PK).
- The identified kinase corresponds to the human cell cycle checkpoint protein ATR; its catalytic activity is essential for DNA-stimulated p53 phosphorylation.
Conclusions:
- ATR functions upstream of p53 in a signal transduction cascade initiated by DNA damage.
- ATR is the kinase responsible for phosphorylating p53 at serine-15 in response to DNA damage.
- A biochemical assay system for ATR activity has been established.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle

